Cognito Therapeutics | * Brent Vaughan Appointed CEO of Cognito Therapeutics

About
Science
Publications
Careers
Media
Contact
Participate

About
Science
Publications
Careers
Media
Contact
Participate

Brent Vaughan Appointed CEO of Cognito Therapeutics

October 12, 2020

Read Article

Stay in the know

Join Our Mailing List

Media
Privacy Policy
Terms of Service

©2021 Cognito Therapeutics, Inc. All rights reserved.

Please click here to view our recent Endpoints Webinar on “Improving Endpoint Selection in Alzheimer’s Disease Trials”.